Anna Ribera
BioPharmaceuticals R&D
Barcelona, CT, Spain
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Clinical characterization and impact of hypophosphatasia in Spain: An observational analysis of the Spanish cohort included in the Global HPP Registry.
Journal: Medicina clinica
Published: March 05, 2025
An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naïve Patients With COPD.
Journal: International journal of chronic obstructive pulmonary disease
Published: May 30, 2019
Efficacy of aclidinium/formoterol 400/12 µg, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of ACLIFORM and AUGMENT.
Journal: International journal of chronic obstructive pulmonary disease
Published: March 19, 2019
The impacts of morning, daytime, and nighttime symptoms on disease burden in real-world patients with COPD.
Journal: International journal of chronic obstructive pulmonary disease
Published: May 29, 2018
Understanding the impact of symptoms on the burden of COPD.
Journal: Respiratory research
Published: February 25, 2017
Aclidinium bromide improves symptoms and sleep quality in COPD: a pilot study.
Journal: The European respiratory journal
Published: November 15, 2016
The efficacy of aclidinium/formoterol on lung function and symptoms in patients with COPD categorized by symptom status: a pooled analysis.
Journal: International journal of chronic obstructive pulmonary disease
Published: September 14, 2016
The Relationship Between 24-Hour Symptoms and COPD Exacerbations and Healthcare Resource Use: Results from an Observational Study (ASSESS).
Journal: COPD
Published: March 18, 2016
Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre study.
Journal: NPJ primary care respiratory medicine
Published: September 23, 2014
Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study.
Journal: Respiratory research
Published: July 14, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026